How well do you know your starting material?
Watch Rob Tressler, Chief Scientific Officer at Excellos, present “Considerations for Donor Starting Material Characterization” from CGT Summit 2025 in Orlando. In this session, Rob explores key factors influencing the quality and consistency of cell and gene therapy products—insights that are essential for advancing the future of CGT.
Ready to strengthen your donor starting material strategy? Contact us to start the conversation.”
